Legal Representation
Attorney
James Surber
USPTO Deadlines
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 15, 2023 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Jun 15, 2023 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Jun 15, 2023 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Mar 1, 2023 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Mar 1, 2023 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Mar 1, 2023 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Jan 18, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 17, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 17, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 13, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 13, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Sep 13, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Aug 2, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 2, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 2, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 21, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 26, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 24, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Dietary and nutritional supplements for the treatment and prevention of inflammation and inflammatory diseases, arthritis, anxiety, depression, dementia, cancer, fibromyalgia, colitis, Crohn's disease, diverticulitis, gastritis, viral infections, and respiratory diseases; Pharmaceutical preparations for the treatment and prevention of inflammation and inflammatory diseases, arthritis, anxiety, depression, dementia, cancer, fibromyalgia, colitis, Crohn's disease, diverticulitis, gastritis, viral infections, and respiratory diseases
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005